Concepedia

Carol Otten-Evans

CO

Statistics

Publications

6

Citations

1.4K

H-Index

6

Active since

1994

Affiliations

Research & Development Corporation(Current)

IDEX Corporation (United States)

Carol Otten-Evans is an author at Research & Development Corporation specializing in life sciences, immunology, and inflammation.

Publications per year

1994–1997

6

Publications

6

Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing

Kendall M. Mohler, Paul R. Sleath, Jeffrey N. Fitzner et al. · Nature · 1994 · 600 citations

, , +11

A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor

Jürgen Müllberg, Fiona H. Durie, Carol Otten-Evans et al. · The Journal of Immunology · 1995 · 252 citations · Full text

, , +15

A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes.

Paul D. Crowe, Barbara Walter, K M Mohler et al. · The Journal of Experimental Medicine · 1995 · 232 citations · Full text

, , +13

Induction of B cell costimulatory function by recombinant murine CD40 ligand

Mary K. Kennedy, Kendall M. Mohler, Kurt Shanebeck et al. · European Journal of Immunology · 1994 · 146 citations

, , +15

Relaxed Specificity of Matrix Metalloproteinases (MMPS) and TIMP Insensitivity of Tumor Necrosis Factor-α (TNF-α) Production Suggest the Major TNF-α Converting Enzyme Is Not an MMP

Roy A. Black, Fiona H. Durie, Carol Otten-Evans et al. · Biochemical and Biophysical Research Communications · 1996 · 71 citations

, , +9

1–5 of 6